Stay updated with breaking news from Serus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cerus Corporation (CERS) announced the FDA has granted approval of 12-month shelf life for INTERCEPT Platelet Processing Sets, from the date of manufacture, effective immediately. ....
- Oral presentation on MCLA-129 in combination with osimertinib as first line therapy, and in previously treated, NSCLC on Sunday, December 3 at 9:40 a.m.. ....